Adient (ADNT)
(Delayed Data from NYSE)
$30.75 USD
+0.33 (1.08%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $30.77 +0.02 (0.07%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.75 USD
+0.33 (1.08%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $30.77 +0.02 (0.07%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth F Momentum A VGM
Zacks News
Copart (CPRT) Declares Common Stock Split in 2-for-1 Ratio
by Zacks Equity Research
Copart, Inc. (CPRT) announced that its board has cleared the split of its common stock in a two-for-one ratio.
Should You Buy Adient (ADNT) Ahead of Earnings?
by Zacks Equity Research
Adient (ADNT) looks like an exciting pick for investors as it is poised to beat at earnings season.